Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Jan 10, 2025

SELL
$460.0 - $505.78 $257,140 - $282,731
-559 Closed
0 $0
Q2 2024

Jan 10, 2025

BUY
$392.81 - $485.53 $9,820 - $12,138
25 Added 4.68%
559 $262 Million
Q1 2024

Jan 10, 2025

BUY
$407.69 - $446.08 $217,706 - $238,206
534 New
534 $223 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Florida Financial Advisors, LLC Portfolio

Follow Florida Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Florida Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Florida Financial Advisors, LLC with notifications on news.